Journal article

Factors associated with poor adherence to antiviral treatment for hepatitis B

N Allard, A Dev, J Dwyer, G Srivatsa, A Thompson, B Cowie

Journal of Viral Hepatitis | Published : 2017

Abstract

Antiviral therapy for hepatitis B is effective and reduces the risk of progression to cirrhosis and liver cancer but is often required for an indefinite duration. Treatment adherence is important to prevent the development of resistance and optimize outcomes. Pharmacy adherence measures can be used to assess treatment adherence, with the medication possession ratio being less susceptible to bias than physician- or self-reported adherence. The aim of this study was to measure adherence in public hospital outpatients over a 3-year period and to examine factors associated with nonadherence. A retrospective study of pharmacy records of patients dispensed antiviral therapy for hepatitis B from fo..

View full abstract